九洲藥業(603456.SH):控股股東非公開發行可交債(第二期)1517.73萬股解押
格隆匯7月21日丨九洲藥業(603456.SH)公佈,近日,公司接到控股股東中貝集團關於股份解除質押的通知,鑑於中貝集團非公開發行2019年可交換公司債券(第二期)(以下簡稱“二期可交債”)已全部完成換股,累計換股2482.2689萬股。中貝集團將“浙江中貝九洲集團有限公司—浙江中貝九洲集團有限公司非公開發行2019年可交換公司債券(第二期)質押專户”(以下簡稱“質押專户”)中剩餘全部股份1517.7311萬股解除質押。
控股股東中貝集團持有公司股份2.84億股(均為無限售流通股),佔公司總股本的35.29%。本次股份解除質押後,中貝集團累計質押股份數量(含本次)為8150萬股,佔其持有公司股份數量的28.75%,佔公司總股本的10.15%。
中貝集團及其一致行動人合計持有公司股份4.199億股(均為無限售流通股),佔公司總股本的52.28%,累計質押股份數量(含本次)為1.095億股,佔其持有公司股份數量的26.07%,佔公司總股本的13.63%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.